Indegene Ltd

  • BSE Code : 544172
  • NSE Symbol : INDGN
  • ISIN : INE065X01017
  • Industry :MISCELLANEOUS

up-arrow 575.00 2.50(0.44%)

Open Price ()

579.95

Prev. Close ()

572.50

Volume (No’s)

302,646

Market Cap ()

13,743.89

Low Price ()

572.85

High Price ()

581.90

 

Board Meetings

Start Date End Date Purpose
27-May-2025 27-May-2025 Re-appointment of Dr. Georgia Nikolakopoulou Papathomas as Independent Director subject to approval of shareholders at the ensuing Annual General Meeting. Outcome of Board Meeting (As Per BSE Announcement dated on 27.05.2025)
21-Apr-2025 28-Apr-2025 Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2025 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Intimation of Outcome of Board Meeting (As per BSE Announcement Dated on 28/04/2025)
19-Mar-2025 19-Mar-2025 Disclosure under Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements)Regulations,2015
24-Jan-2025 30-Jan-2025 Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve 1. The unaudited consolidated financial results of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter December 31 2024 along with the limited review report of the Auditors thereon. 2. The unaudited standalone financial results of the Company as per INDAS for the quarter December 312024 along with the limited review report of the Auditors thereon. 3. Appointment of statutory auditor for five financial years commencing from 2025-26 and to hold such office till the conclusion of Annual General Meeting to be held for the Financial Year 2029-30. 4. Approval of allotment under ESOP Scheme 2020 RSU Scheme 2020 The unaudited consolidated financial results of the company and its subsidiaries as per [INDAS] for the quarter ended December 31, 2024 along with the Limited review report of the Auditors thereon. The unaudited standalone financial results of the company as per [INDAS] for the quarter ended December 31, 2024 along with the limited review report of the Auditors thereon. To Allot shares under ESOP 2020 plan & RSU 2020 plan. (As Per BSE Announcement Dated on: 30/01/2025) Integrated Filing (financial) for the quarter ended 31st December 2024 (As Per BSE Announcement dated on 10.02.2025)
12-Nov-2024 15-Nov-2024 Pursuant to Regulation 30 of the SEBI[LODR] Regulation, 2015, We hereby inform you that the following resolutions of Board of Directors of Indegene Limited are scheduled to be circulated on Friday, November 15, 2024. 1. To allot shares under ESOP 2020 Plan- with bonus element. 2. To allot shares under ESOP 2020 plan- Without bonus element. 3. To allot shares under RSU 2020 plan- With bonus element. 4. To allot shares under RSU 2020 Plan - Without bonus element.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew